Development of new HLA-B*3505 genotyping method using invader assay

Naoya Hosono, Soranun Chantarangsu, Kazuma Kiyotani, Sadaaki Takata, Yumiko Tsuchiya, Surakameth Mahasirimongkol, Wasun Chantratita, Taisei Mushiroda, Yusuke Nakamura, Michiaki Kubo

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Several pharmacogenetic studies have revealed strong associations between specific human leukocyte antigen (HLA) alleles and the susceptibility to drug hypersensitivity. Recently, we reported HLA-B*3505 as a strong genetic biomarker for the nevirapine-induced skin rash in Thai population. Here, we developed a new HLA-B*3505 genotyping method by a combination of the Universal Invader assay and sequence-specific primer PCR. From the sequence alignment of 68 HLA-B alleles in the Thai population, we selected the two most discriminative SNPs (rs1140412 and rs4997052) as target SNP sites. When we carried out the assay using 324 Thai individuals, fluorescence intensities of HLA-B*3505-positive and HLA-B*3505-negative samples were apparently discriminated at the endpoint of the reaction. Our results were 100% concordant with those obtained by a sequence-based typing method. As our assay is simple and rapid, we believe our method will be a useful tool for pharmacogenetic testing of the nevirapine-induced skin rash.

Original languageEnglish
Pages (from-to)630-633
Number of pages4
JournalPharmacogenetics and Genomics
Volume20
Issue number10
DOIs
Publication statusPublished - 01-10-2010
Externally publishedYes

Fingerprint

HLA Antigens
Nevirapine
Exanthema
Single Nucleotide Polymorphism
Alleles
Drug Hypersensitivity
Sequence Alignment
Population
Biomarkers
Fluorescence
Polymerase Chain Reaction

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Genetics(clinical)

Cite this

Hosono, N., Chantarangsu, S., Kiyotani, K., Takata, S., Tsuchiya, Y., Mahasirimongkol, S., ... Kubo, M. (2010). Development of new HLA-B*3505 genotyping method using invader assay. Pharmacogenetics and Genomics, 20(10), 630-633. https://doi.org/10.1097/FPC.0b013e32833ddc0a
Hosono, Naoya ; Chantarangsu, Soranun ; Kiyotani, Kazuma ; Takata, Sadaaki ; Tsuchiya, Yumiko ; Mahasirimongkol, Surakameth ; Chantratita, Wasun ; Mushiroda, Taisei ; Nakamura, Yusuke ; Kubo, Michiaki. / Development of new HLA-B*3505 genotyping method using invader assay. In: Pharmacogenetics and Genomics. 2010 ; Vol. 20, No. 10. pp. 630-633.
@article{02838186f0594008a965dff13c6a93ee,
title = "Development of new HLA-B*3505 genotyping method using invader assay",
abstract = "Several pharmacogenetic studies have revealed strong associations between specific human leukocyte antigen (HLA) alleles and the susceptibility to drug hypersensitivity. Recently, we reported HLA-B*3505 as a strong genetic biomarker for the nevirapine-induced skin rash in Thai population. Here, we developed a new HLA-B*3505 genotyping method by a combination of the Universal Invader assay and sequence-specific primer PCR. From the sequence alignment of 68 HLA-B alleles in the Thai population, we selected the two most discriminative SNPs (rs1140412 and rs4997052) as target SNP sites. When we carried out the assay using 324 Thai individuals, fluorescence intensities of HLA-B*3505-positive and HLA-B*3505-negative samples were apparently discriminated at the endpoint of the reaction. Our results were 100{\%} concordant with those obtained by a sequence-based typing method. As our assay is simple and rapid, we believe our method will be a useful tool for pharmacogenetic testing of the nevirapine-induced skin rash.",
author = "Naoya Hosono and Soranun Chantarangsu and Kazuma Kiyotani and Sadaaki Takata and Yumiko Tsuchiya and Surakameth Mahasirimongkol and Wasun Chantratita and Taisei Mushiroda and Yusuke Nakamura and Michiaki Kubo",
year = "2010",
month = "10",
day = "1",
doi = "10.1097/FPC.0b013e32833ddc0a",
language = "English",
volume = "20",
pages = "630--633",
journal = "Pharmacogenetics and Genomics",
issn = "1744-6872",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

Hosono, N, Chantarangsu, S, Kiyotani, K, Takata, S, Tsuchiya, Y, Mahasirimongkol, S, Chantratita, W, Mushiroda, T, Nakamura, Y & Kubo, M 2010, 'Development of new HLA-B*3505 genotyping method using invader assay', Pharmacogenetics and Genomics, vol. 20, no. 10, pp. 630-633. https://doi.org/10.1097/FPC.0b013e32833ddc0a

Development of new HLA-B*3505 genotyping method using invader assay. / Hosono, Naoya; Chantarangsu, Soranun; Kiyotani, Kazuma; Takata, Sadaaki; Tsuchiya, Yumiko; Mahasirimongkol, Surakameth; Chantratita, Wasun; Mushiroda, Taisei; Nakamura, Yusuke; Kubo, Michiaki.

In: Pharmacogenetics and Genomics, Vol. 20, No. 10, 01.10.2010, p. 630-633.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Development of new HLA-B*3505 genotyping method using invader assay

AU - Hosono, Naoya

AU - Chantarangsu, Soranun

AU - Kiyotani, Kazuma

AU - Takata, Sadaaki

AU - Tsuchiya, Yumiko

AU - Mahasirimongkol, Surakameth

AU - Chantratita, Wasun

AU - Mushiroda, Taisei

AU - Nakamura, Yusuke

AU - Kubo, Michiaki

PY - 2010/10/1

Y1 - 2010/10/1

N2 - Several pharmacogenetic studies have revealed strong associations between specific human leukocyte antigen (HLA) alleles and the susceptibility to drug hypersensitivity. Recently, we reported HLA-B*3505 as a strong genetic biomarker for the nevirapine-induced skin rash in Thai population. Here, we developed a new HLA-B*3505 genotyping method by a combination of the Universal Invader assay and sequence-specific primer PCR. From the sequence alignment of 68 HLA-B alleles in the Thai population, we selected the two most discriminative SNPs (rs1140412 and rs4997052) as target SNP sites. When we carried out the assay using 324 Thai individuals, fluorescence intensities of HLA-B*3505-positive and HLA-B*3505-negative samples were apparently discriminated at the endpoint of the reaction. Our results were 100% concordant with those obtained by a sequence-based typing method. As our assay is simple and rapid, we believe our method will be a useful tool for pharmacogenetic testing of the nevirapine-induced skin rash.

AB - Several pharmacogenetic studies have revealed strong associations between specific human leukocyte antigen (HLA) alleles and the susceptibility to drug hypersensitivity. Recently, we reported HLA-B*3505 as a strong genetic biomarker for the nevirapine-induced skin rash in Thai population. Here, we developed a new HLA-B*3505 genotyping method by a combination of the Universal Invader assay and sequence-specific primer PCR. From the sequence alignment of 68 HLA-B alleles in the Thai population, we selected the two most discriminative SNPs (rs1140412 and rs4997052) as target SNP sites. When we carried out the assay using 324 Thai individuals, fluorescence intensities of HLA-B*3505-positive and HLA-B*3505-negative samples were apparently discriminated at the endpoint of the reaction. Our results were 100% concordant with those obtained by a sequence-based typing method. As our assay is simple and rapid, we believe our method will be a useful tool for pharmacogenetic testing of the nevirapine-induced skin rash.

UR - http://www.scopus.com/inward/record.url?scp=77957222123&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957222123&partnerID=8YFLogxK

U2 - 10.1097/FPC.0b013e32833ddc0a

DO - 10.1097/FPC.0b013e32833ddc0a

M3 - Article

C2 - 20679961

AN - SCOPUS:77957222123

VL - 20

SP - 630

EP - 633

JO - Pharmacogenetics and Genomics

JF - Pharmacogenetics and Genomics

SN - 1744-6872

IS - 10

ER -

Hosono N, Chantarangsu S, Kiyotani K, Takata S, Tsuchiya Y, Mahasirimongkol S et al. Development of new HLA-B*3505 genotyping method using invader assay. Pharmacogenetics and Genomics. 2010 Oct 1;20(10):630-633. https://doi.org/10.1097/FPC.0b013e32833ddc0a